Improvement in the pharmacological profile of copper biological active complexes by their incorporation into organic or inorganic matrix

M Badea, V Uivarosi, R Olar - Molecules, 2020 - mdpi.com
Every year, more Cu (II) complexes are proven to be biologically active species, but very few
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …

Polyglycerol‐Based Copper Chelators for the Transport and Release of Copper Ions in Biological Environments

R Albrecht, S Fehse, K Pant, S Nowag… - Macromolecular …, 2016 - Wiley Online Library
Here, the synthesis and characterization of three improved nanosystems is presented based
on amino functionalized hyperbranched polyglycerol (hPG; Mw= 16.8 kDa) as potential …

Zn (II) and Cu (II) complexes containing bioactive O, O-chelated ligands: homoleptic and heteroleptic metal-based biomolecules

BS Mendiguchia, I Aiello, A Crispini - Dalton Transactions, 2015 - pubs.rsc.org
Historically, many useful drugs have been developed from natural sources and their
mechanisms of action deeply investigated for therapeutic applications. Recently, the …

Therapeutic potential of a copper complex loaded in pH-sensitive long circulating liposomes for colon cancer management

JO Pinho, IV da Silva, JD Amaral… - International Journal of …, 2021 - Elsevier
Colorectal carcinoma is a complex malignancy and current therapies are hampered by
systemic toxicity and tumor resistance to treatment. In the field of cancer therapy, copper …

Liposomal form of 2-alkylthioimidazolone-based copper complexes for combined cancer therapy

TM Iakimova, AA Bubley, OP Boychenko, DA Guk… - …, 2023 - Future Medicine
Aim: To develop an optimized approach for encapsulating a 2-alkylthioimidazolone-based
copper coordination compound within liposomes, which could offer treatment of cancer and …

A Nanostructured Lipid System as a Strategy to Improve the in Vitro Antibacterial Activity of Copper(II) Complexes

PB Silva, BV Bonifácio, RCG Frem, AV Godoy Netto… - Molecules, 2015 - mdpi.com
The aim of this study was to construct a nanostructured lipid system as a strategy to improve
the in vitro antibacterial activity of copper (II) complexes. New compounds with the general …

Bioinorganic Chemistry of Copper: From Biochemistry to Pharmacology

AM Da Costa Ferreira, C Hureau, G Facchin - Inorganics, 2024 - mdpi.com
Copper is an essential trace element found ubiquitously in humans [1, 2], plants [3–5],
vertebrates and invertebrates [6], and is present in different active sites at innumerous …

Exploring the therapeutic potential of Cu (II)-complexes with ligands derived from pyridoxal

P Nunes, F Marques, I Cavaco, JC Pessoa… - Inorganica Chimica …, 2020 - Elsevier
Three new copper (II) complexes formulated as [Cu (L)(X)], where X= H 2 O or Cl and H 2 L
is a Schiff base (H 2 L 1, 2) or its reduced version (H 3 L 3 Cl) derived from pyridoxal, are …

Development of copper based drugs, radiopharmaceuticals and medical materials

P Szymański, T Frączek, M Markowicz… - Biometals, 2012 - Springer
Copper is one of the most interesting elements for various biomedical applications. Copper
compounds show vast array of biological actions, including anti-inflammatory, anti …

Copper chelators: chemical properties and bio-medical applications

M Tegoni, D Valensin, L Toso… - Current medicinal …, 2014 - ingentaconnect.com
Copper is present in different concentrations and chemical forms throughout the earth crust,
surface and deep water and even, in trace amounts, in the atmosphere itself. Copper is one …